Estrogen-Estrogen Receptor axis in non-transformed breast epithelial cells: studies beyond MCF-7
非转化乳腺上皮细胞中的雌激素-雌激素受体轴:MCF-7 以外的研究
基本信息
- 批准号:9024970
- 负责人:
- 金额:$ 7.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-04 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeBRCA1 geneBindingBinding SitesBioinformaticsBiological AssayBiologyBreastBreast Cancer cell lineBreast Epithelial CellsCancer cell lineCell FractionCell LineCellsChIP-seqClinicalCommunitiesCyclin D1DNA Modification MethylasesDataData SetDefectDevelopmentDrug TargetingElementsEpithelial CellsEstrogen AntagonistsEstrogen Receptor alphaEstrogen ReceptorsEstrogen TherapyEstrogensEventGene ExpressionGene Expression ProfileGene TargetingGenesGenetic TranscriptionGenomeGenomic SegmentGenomicsGoalsGrowthHistone Deacetylase InhibitorHormonesHumanIndividualInterphase CellKnowledgeLigandsLightLinkLiteratureMCF7 cellMalignant NeoplasmsMammary glandMenstrual cycleMethodsMusMutationNormal CellNuclear ReceptorsOncogenicPathway interactionsPatientsPatternPlayPregnancyProgesteroneProliferatingProtein-Serine-Threonine KinasesProto-Oncogene Proteins c-aktReceptor SignalingRepressionResearchResistanceResourcesRoleSignal PathwaySignal TransductionStem cellsSupporting CellSystemTelomeraseTestingTransforming Growth Factor betaTumor Suppressor GenesUbiquitinationc-Myc Staining Methodcancer cellcell transformationcell typechromatin modificationgene repressiongenome-widegenomic aberrationshigh riskimmortalized cellmalignant breast neoplasmmouse modelmutantparacrinepreventprogenitorprognosticprogramspublic health relevanceresponsetooltranscription factortranscriptometranscriptome sequencingtumor
项目摘要
DESCRIPTION (provided by applicant): Estrogen (E2) acting through the nuclear receptor estrogen receptor alpha (ERα) plays a major role in breast cancer. Approximately 70% of breast cancers express ERα and patients with ERα-positive breast cancers receive anti-estrogens. However, resistance to anti-estrogen therapy is a major clinical problem. There are at least two critical unresolved issues in this field: 1) in the normal breast, ERα is expressed in 10-20% of non- dividing cells. These ERα-positive cells support proliferation of ERα-negative cells in response to E2 through paracrine action. In contrast to normal cells, ERα-positive cancer cells themselves proliferate in response to E2. Mechanisms governing switch in this ERα function are largely unknown and is the focus of this proposal; 2) Mechanisms of anti-estrogen resistance. Most of our current knowledge of ERα biology including genome- wide binding pattern (ERα cistrome), the role of pioneer factors/chromatin modifications in guiding ERα cistrome, and E2-regulated gene expression pattern (E2-transcriptome) are from studies using the cancer cell line MCF-7 but not normal/non-transformed cells because it has not been technically possible to culture ERα- expressing non-transformed cells. This limitation has prevented us from understanding the function of ERα in the normal breast and mechanisms that govern cancer-associated shift in ERα function. To address these critical issues, we generated several ERα-positive breast epithelial cell lines by propagating cells from normal breast using recently described epithelial cell-reprogramming assay followed by immortalization using the hTERT. Consistent with the predicted expression pattern of ERα in primary cells, ERα is expressed in the luminal progenitor and mature cell but not in stem cell fraction of these cell lines, which authenticates the relevance of the system. RNA-seq analysis of one of these cell lines showed dominant action of ERα:E2 in repressing gene expression. In contrast, ERα-signaling involved both activation and repression in cancer cells and was well integrated with PI3K-Cyclin D1-cMyc proliferation network as well as an atypical ubiquitination system not seen in normal cells. Using these new resources, we will address the hypothesis that switch in ERα cistrome and E2-transciptome from a repressor mode to a activator mode is a critical early step in ERα- positive breast cancer. The specific aims are to: 1) Define ERα cistrome that is unique to non-transformed breast epithelial cells; 2) Investigate signaling nodes that govern ERα function in non-transformed and transformed breast epithelial cells by integrating ERα cistrome with transcriptome. Impact: To our knowledge, this is the first study to determine ERα function in non-transformed breast epithelial cells. The resources developed will be valuable to the research community to reassess signaling networks associated with ERα-positive breast cancer and anti-estrogen resistance. In particular, signaling defects linked to genomic aberrations uniquely enriched in ERα-positive breast cancers can be investigated and drugs targeting specific aberration can be identified using this resource.
描述(由申请人提供):雌激素(E2)通过核受体雌激素受体α(ERα)发挥作用,在乳腺癌中起主要作用。大约70%的乳腺癌表达ERα,ERα阳性乳腺癌患者接受抗雌激素治疗。然而,对抗雌激素治疗的抗性是一个主要的临床问题。在这一领域至少有两个关键的未解决的问题:1)在正常乳腺中,ERα在10-20%的非分裂细胞中表达。这些ERα阳性细胞通过旁分泌作用支持ERα阴性细胞对E2的增殖反应。与正常细胞相反,ERα阳性癌细胞本身对E2有反应而增殖。控制ERα功能转换的机制在很大程度上是未知的,这是本提案的重点; 2)抗雌激素抵抗的机制。我们目前对ERα生物学的大多数了解,包括全基因组结合模式(ERα顺式组)、先锋因子/染色质修饰在引导ERα顺式组中的作用以及E2调节的基因表达模式(E2-转录组),都来自使用癌细胞系MCF-7而非正常/非转化细胞的研究,因为在技术上不可能培养表达ERα的非转化细胞。这种局限性使我们无法理解ERα在正常乳腺中的功能以及控制癌症相关ERα功能变化的机制。为了解决这些关键问题,我们通过使用最近描述的上皮细胞重编程测定法从正常乳腺增殖细胞,然后使用hTERT永生化,产生了几种ERα阳性乳腺上皮细胞系。与原代细胞中ERα的预测表达模式一致,ERα在管腔祖细胞和成熟细胞中表达,但在这些细胞系的干细胞部分中不表达,这验证了该系统的相关性。其中一个细胞系的RNA-seq分析显示ERα:E2在抑制基因表达中起主导作用。相反,ERα-信号通路在癌细胞中涉及激活和抑制,并与PI 3 K-Cyclin D1-cMyc增殖网络以及正常细胞中未观察到的非典型泛素化系统良好整合。利用这些新的资源,我们将解决这样的假设,即ERα顺式组和E2-transciptome从阻遏模式到激活模式的转换是ERα阳性乳腺癌的关键早期步骤。具体目标是:1)定义非转化乳腺上皮细胞所特有的ERα顺反子组; 2)通过整合ERα顺反子组与转录组来研究在非转化和转化乳腺上皮细胞中控制ERα功能的信号传导节点。影响:据我们所知,这是第一项确定ERα在非转化乳腺上皮细胞中功能的研究。开发的资源将对研究界重新评估与ERα阳性乳腺癌和抗雌激素抵抗相关的信号网络具有价值。特别是,可以研究与ERα阳性乳腺癌中独特富集的基因组畸变相关的信号传导缺陷,并且可以使用该资源鉴定靶向特定畸变的药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harikrishna Nakshatri其他文献
Harikrishna Nakshatri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harikrishna Nakshatri', 18)}}的其他基金
Summer Program for Academic Research in Cancer (SPARC)
癌症学术研究暑期项目 (SPARC)
- 批准号:
10628221 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
- 批准号:
10515659 - 财政年份:2015
- 资助金额:
$ 7.8万 - 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
- 批准号:
10296651 - 财政年份:2015
- 资助金额:
$ 7.8万 - 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
- 批准号:
10043823 - 财政年份:2015
- 资助金额:
$ 7.8万 - 项目类别:
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
炭疽毒素受体作为乳腺癌干细胞的标记和靶标
- 批准号:
8113776 - 财政年份:2011
- 资助金额:
$ 7.8万 - 项目类别:
Persistent microRNA changes in serum of cancer-free breast cancer patients
无癌乳腺癌患者血清中持续的 microRNA 变化
- 批准号:
8240038 - 财政年份:2011
- 资助金额:
$ 7.8万 - 项目类别:
Persistent microRNA changes in serum of cancer-free breast cancer patients
无癌乳腺癌患者血清中持续的 microRNA 变化
- 批准号:
8104694 - 财政年份:2011
- 资助金额:
$ 7.8万 - 项目类别:
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
炭疽毒素受体作为乳腺癌干细胞的标记和靶标
- 批准号:
8244440 - 财政年份:2011
- 资助金额:
$ 7.8万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Research Grant